Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Lolli, Cristian; Caffo, Orazio; Scarpi, Emanuela; Aieta, Michele; Conteduca, Vincenza; Maines, Francesca; Bianchi, Emanuela; Massari, Francesco; Veccia, Antonello; Emanuele Chiurì, Vincenzo; Facchini, Gaetano; De Giorgi, Ugo

doi:10.3389/fphar.2016.00376

Public

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Published in Frontiers in Pharmacology • Oct 13, 2016

Authors:

Cristian Lolli

Orazio Caffo

Emanuela Scarpi

Abstract

Background: A systemic immune-inflammation index (SII) based on neutrophil (N), lymphocyte (L), and platelet (P) counts has shown a prognostic impact in several solid tumors. The aim of this study is to evaluate the prognostic role of SII in mCRPC patients treated with abiraterone post docetaxel. Pa...

Subject

Medicine

Internal medicine

Enzalutamide

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!